Following neoadjuvant chemotherapy, surgeries were upgraded in less than 14% of cases, despite a significant trend of tumour growth observed during chemotherapy and affecting 75% of cases.
← all excerpts
Evaluation of the effect of neoadjuvant chemotherapy on the planned resectability of extremity soft-tissue sarcomas.
1
—
—